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Bupivacaine inhibits cardiac conduction and contractility. Insulin enhances cardiac repolarization and myocardial contractility.
We hypothesizes that insulin therapy would be eﬀective in resuscitating bupivacaine-induced cardiac toxicity in rabbits. Twelve
rabbits were tracheally intubated and midline sternotomy was performed under general anesthesia. Cardiovascular collapse
(CVC) was induced by an IV bolus injection of bupivacaine 10mg/kg. The rabbits were treated with either saline (control)
or insulin injection, administered as a 2U/kg bolus. Internal cardiac massage was performed until the return of spontaneous
circulation (ROSC) and the time to the return of sinus rhythm (ROSR) was also noted in both groups. Arterial blood pressure,
and electrocardiography were continuously monitored for 30min and plasma bupivacaine concentrations at every 5min. The
ROSC, ROSR and normalization of QRS duration were attained faster in the insulin-treated group than in the control group. At
the ROSC, there was a signiﬁcant diﬀerence in bupivacaine concentration between two groups. Insulin facilitates the return of
myocardial contractility and conduction from bupivacaine-induced CVC in rabbits. However, recovery of cardiac conduction is
dependent mainly on the change of plasma bupivacaine concentrations.
1.Introduction
Resuscitation following bupivacaine-induced cardiovascular
collapse(CVC) isdiﬃcultand oftenresistantto conventional
treatment [1]. Bupivacaine blocks cardiac Na+ channel [2, 3]
and transient outward K+ currents [4]. Increased ECG inter-
vals [5] and decreased R-wave amplitude in lead II [6]a r e
shown by the bupivacaine infusion. Bupivacaine also de-
creases the maximal rate of depolarization in Purkinje ﬁbers
[7]. Alteration of Ca++ recruitment from sarcoplasmic ret-
iculum [8] and mitochondrial ATP production [9] are re-
lated to the deterioration of myocardial contractility by
bupivacaine.
Previous experiments have shown that insulin might be
eﬀective in reversing bupivacaine-induced cardiac depres-
sion probably by enhancing transient outward K+ current,
Ca++ transport activity of sarcoplasmic reticulum, and im-
provingmyocardialenergetics[5,10].Incontrast,Stehretal.
demonstrate that insulin has a signiﬁcant positive inotropic
eﬀect without aﬀecting electrophysiologic parameters at a
ﬁxed bupivacaine concentration in an in vitro study [11].
Because bupivacaine impairs ventricular conduction in a
dose-dependent manner and QRS widening has been shown
asafunctionofbupivacaineconcentrationinanisolatedrab-
bit heart model [12], we assume that insulin might facilitate
myocardialcontractilityandconductionduringresuscitation2 Anesthesiology Research and Practice
Table 1: Changes of hemodynamics, bupivacaine concentration and QRS duration in the control and insulin groups.
Group Baseline CVC 5min 10min 15min 20min 25min 30min
HR (/min)
Control 184 ±30 13 ±30† 102 ±14† 153 ±21† 173 ±25 215 ±32 221 ±31 219 ±22
Insulin 162 ±36 21 ±27† 109 ±24† 150 ±18 189 ±31 185 ±26 188 ±31 188 ±34
MAP (mmHg)
Control 88 ±11 13 ±4† 48 ±9† 43 ±6† 50 ±15† 61 ±25† 70 ±22 84 ±13
Insulin 85 ±15 13 ±2† 44 ±6† 36±7† 58±15† 72 ±7† 73 ±77 7 ±9
CPP (mmHg)
Control 73 ±12 6 ±1† 23 ±12† 20 ±13† 29 ±20† 48 ±28 58 ±21 73 ±12
Insulin 69 ±13 7 ±3† 20 ±11† 19 ±7† 43 ±18† 58 ±8† 61 ±86 4 ±10
Bupivacaine (ug/dL)
Control 84.89 ±44.88† 3.21 ±0.51† 2.02 ±0.42† 1.59 ±0.31† 1.41 ±0.31† 1.21 ±0.41† 1.09 ±0.11†
Insulin 77.45 ±51.65† 3.42 ±1.02† 2.21 ±0.41† 1.81 ±0.39† 1.62 ±0.19† 1.49 ±0.29† 1.19 ±0.11†
QRS (msec)
Control 46 ±9 168 ±89† 178 ±33† 173 ±37† 171 ±41† 75 ±34† 65 ±22† 55 ±9
Insulin 48 ±9 186 ±93† 182 ±48† 176 ±50† 71 ±12†,∗ 58 ±12 58 ±85 9 ±9
Values are mean ± SD.
CVC: cardiovascular collapse; HR: heart rate; MAP: mean arterial pressure; CPP: coronary perfusion pressure.
∗P<0.05 versus control; †P<0.05 versus baseline.
of bupivacaine-induced CVC in vivo. The purpose of this
study was to generate CVC by a bolus injection of bupiva-
caine in rabbits and evaluate the eﬀect of insulin treatment
with an internal cardiac massage on the recovery of the he-
modynamic and electrocardiographic variables while mea-
suring plasma bupivacaine concentration.
2.MaterialsandMethods
This study was approved by the Institutional Animal Care
and Use Committee of Seoul National University Hospital
(07-0167). Twelve New Zealand white rabbits (about 3kg)
were sedated with ketamine 15mg/kg and xylazine 10mg/kg
intramuscularly. A 22-gauge venous catheter was placed into
the marginal ear vein. The trachea was intubated with a
3.0mm cuﬀed tube; thereafter, vecuronium 0.2mg/kg was
injected IV, followed by 0.02mg/kg at 30min intervals. The
animals were placed in a supine position and mechanical
ventilation was accomplished with a Servo 900C ventilator
(SIEMENS,Erlangen,Germany)tomaintainnormocarbiaat
a fraction of inspired oxygen (FIO2) of 0.3. Anesthesia was
maintained with a continuous infusion of sodium pentobar-
bital 5mg/kg/hr. Ringer’s lactate solution was infused at a
rate of 10mL/kg/hr. Rectal temperature was maintained at
38-39◦C with a heating pad. The carotid artery was cannu-
latedforarterialpressuremonitoringandbloodgassampling
andthejugularveinforcentralvenouspressure(CVP)moni-
toring and drug administration. Lead II of the electrocar-
diogram (ECG) was recorded continuously. The heart was
exposed through the midline sternotomy for internal cardiac
massage.
Eachrabbitreceivedabolusinfusionof10mg/kgbupiva-
caine over 5 seconds. The time was measured at the onset of
criteriaforCVC(heartrate(HR)<65andmeanarterialpres-
sure (MAP) below 20mmHg), when the rabbits were ran-
domly assigned to two groups: control (C) and insulin (I)
groups (n = 6 in each group). At CVC, pentobarbital infu-
sion was discontinued and FIO2 was elevated to 1.0. Internal
cardiac massage was immediately accomplished at a rate of
more than 150/min to keep MAP higher than 40mmHg.
An IV bolus of 0.9% normal saline 2mL/kg was given to the
C group and regular insulin 2U/kg (1U/mL) to the I group.
Sodium bicarbonate wasadministered asneeded tomaintain
an arterial pH value of 7.35–7.45.
The elapsed time till the return of spontaneous contrac-
tion (ROSC) was deﬁned when MAP over 40mmHg was
maintained longer than 1min without cardiac massage. The
returnofsinusrhythm(ROSR)afterCVCwasalsomeasured.
MAP, HR, CVP, and ECG were continuously monitored and
recorded at 1-minute interval for 30min after CVC. An ECG
analysis system (MAC 8 Marquette, Los Angeles, CA, USA)
was used to measure QRS duration every 5min and at the
time of ROSC and ROSR.
Coronary perfusion pressure (CPP) was estimated by the
arterial pressure-to-CVP gradient during the relaxation
phases of cardiac contraction. Arterial blood samples were
collected for gas analysis and measurement of serum Na+,
K+,C a ++, glucose at baseline, at CVC, and every 5min for
30min, and plasma bupivacaine concentrations were also
measured at CVC, ROSC, and ROSR as well as every 5min.
At the end of each experiment, the rabbits were killed
with KCL 10mEq IV. Blood samples for a bupivacaine con-
centration assay were centrifuged at 2500rpm for 20min,
and the plasma was stored at −50◦C until analyzed by high-
performance liquid chromatography.
Data were expressed as mean ± SD. The diﬀerences be-
tween two groups were identiﬁed with two-way analysis of
variance. Changes over time within each group were evalu-
ated by using analysis of variance for repeated measure with
Bonferroni correction. SPSS (12.0K) was used for the statis-
tical analysis. A value of P<0.05 was considered statistically
signiﬁcant.
3. Results
The two groups were comparable with respect to baseline
hemodynamic variables (Table 1) and hemoglobin concen-
tration (11.4 ± 0.8mg/dL of C group 10.4 ± 1.4mg/dL of
I group). The time needed to CVC was 13 ± 6sec in the C
group, and 17 ± 12sec in the I group. All animals survivedAnesthesiology Research and Practice 3
by the internal cardiac massage delivered at the onset of CVC
till the time of ROSC.
The ROSC was reached at 20 ±5min in the C group and
at 8±4min(P<0.05) in the I group. The ROSR appeared at
20 ± 6min spontaneously after CVC in the C group and at
15±3min(P<0.05)intheIgroup.AttheROSC,theplasma
bupivacaine concentrations were 1.51 ± 0.37ug/mL in the
Cg r o u p ,a n d2 .31 ± 0.18ug/mL (P<0.05) in the I group.
However, the bupivacaine concentrations on ROSR were
1.48 ± 0.28ug/mL in the C group and 1.87 ± 0.26ug/mL in
the I group without signiﬁcant diﬀerence.
The time course of HR, MAP, CPP, and bupivacaine con-
centration was similar in both groups for 30min. QRS dura-
tion was prolonged on CVC and returned to baseline level
at 30min in the C group and at 20min in the I group. At
15minafterCVC,QRSdurationoftheCgroup(171±41ms)
was longer than that (71 ± 12ms) of the I group (P<0.05)
(Table 1).
Arterial pH, PaO2,P a C O 2,N a +,K +,C a ++,a n dg l u c o s e
were comparable in both groups for 30min (Table 2). PaO2
increased from 5min at the FIO2 of 1.0 in both groups.
PaCO2 was signiﬁcantly low on CVC in both groups and
maintained within normal range thereafter. K+ level of the
I group decreased signiﬁcantly after 10min of insulin injec-
tion;however,itshowednosigniﬁcantbetween-groupdiﬀer-
encesfor30min.BloodglucoseleveloftheIgroupdecreased
after 15min without signiﬁcant diﬀerence, compared with
the C group.
ECGchangesandarterialblood pressurewavesofanani-
mal representing each group were shown in Figure 1.T h e
lead II ECG of both animals showed sinus arrest on CVC
when open cardiac compression was begun shortly there-
after. The second rabbit in the C group showed the ROSC
andROSRafter18.7minand19minfromCVC,andtheﬁfth
in the I group restored the ROSC and ROSR after 7min and
13.7min, respectively.
4. Discussion
We designed this study to observe the insulin eﬀect on the
recovery of cardiac hemodynamics and conduction during
resuscitation after a bolus injection of bupivacaine in rab-
bits. The results showed that the recovery of ventricular con-
traction and conduction was enhanced after the insulin
administration as compared with the control group during
cardiac compression.
BupivacaineblocksNa+ channelandtherebyinhibitscar-
diac conductance by binding preferentially to the inactivated
state of the sodium channel in ventricular muscle [3]. Bupi-
vacaine also inhibits transient outward potassium current
(Ito) which is associated with myocardial repolarization [4]
and depresses cardiac contractility by altering Ca++ release
and Ca++ sequestration of the sarcoplasmic reticulum and
decreases myoﬁbrillar activation [13]. In contrast, insulin
increases Ca++ transport activity of sarcoplasmic reticulum
[14]. Transient outward K+ current is enhanced by insulin
[15]. Since cardiac depressant eﬀects of bupivacaine can be
attenuated by shortening the action potential duration [3],
Ito facilitated by insulin may promote depolarization, thus
beneﬁcial in reducing bupivacaine cardiotoxicity [4].
Bupivacaine was continuously infused in the previous
studies using a dog model; thus cardiac depression was grad-
ually induced [5, 10]. In this study, the eﬀect of insulin was
compared after bupivacaine was injected as a bolus dose and
CVC was induced suddenly. About 15 seconds were taken to
reach MAP below 20mmHg and HR lower than 65/min
after the bolus injection. In clinical situation, accidental ad-
ministration of bupivacaine into systemic circulation may
occur in a drastic manner, therefore, resulting in a severe
cardiotoxicity which needs prompt resuscitation including
cardiac massage.
Bupivacaine increases the QRS duration in a dose-de-
pendent manner, while this impairment in ventricular
conductionbybupivacaineisratedependent[12].Therefore,
we tried to prove the insulin eﬀect on the recovery of cardiac
conduction in rabbits with higher baseline HR. In a pilot
study, rabbits failed to recover spontaneously in the criteria
of CVC (HR < 65/min and MBP below 20mmHg) induced
by a bolus injection of bupivacaine. In our experimental
protocol, internal cardiac massage was continued till the
time of ROSC and terminated thereafter. Myocardial blood
ﬂow is dependent on the aortic-to-right atrial pressure gra-
dient during the relaxation phase of cardiac compression.
CPP has been recommended more than 15 to 20mmHg in
cardiopulmonary resuscitation [16]. By the similar changes
of MAP and CPP between two groups, we believe that
internalcardiacmassagetillROSCwaseﬀectiveinproducing
cardiac output for all animals.
The decrease in contractility measured by the dP/dtmax is
linearly correlated with the bupivacaine concentration [12].
In this study, ROSC was reached faster with higher bupiva-
caine concentration in insulin-treated animals. The earlier
recovery of arterial blood pressure at higher plasma bupi-
vacaine level might be due to the positive inotropic eﬀect
of insulin [11]. As expected, ROSR was slower than ROSC
because bupivacaine impairs ventricular conduction more
than contractility [12].
ROSR appeared earlier in the insulin-treated group, but
the bupivacaine concentrations on ROSR in both groups
werenotdiﬀerentsigniﬁcantly.Thisﬁndingprobablyimplies
that insulin eﬀect on cardiac conduction is mainly depen-
dent on the change of plasma bupivacaine concentrations.
Bupivacaine did not change cardiac automaticity but had a
depressant eﬀect on conduction at atrial, ventricular, and
atrioventricular levels [17]. Thus, the sinus rhythm can be
generated at a lower bupivacaine concentration where atrial
electrical impulse can reach ventricular purkinje ﬁbers via
the atrioventricular node, resulting in the synchronous con-
tractionofventricularmyocardium.However,fasterrecovery
ofQRScomplexdurationintheinsulin-treatedgroupreveals
that ventricular conduction was enhanced by the insulin,
resulting in the reduction of action potential duration [15].
Acidosis and hypoxia markedly potentiate cardiac toxi-
city [18]. Hence, FIO2 was changed from initial 0.3 to 1.0
at the onset of CVC, and sodium bicarbonate was infused
to maintain arterial pH. The values of pH were maintained
equally normal in both groups. Despite the eﬀect of insulin4 Anesthesiology Research and Practice
The ﬁfth rabbit in the insulin group The second rabbit in the control group
(a) Baseline (f) Baseline
(b) CVC (g) CVC
(c) ROSC, CM 18.7 min
(d) ROSR, 19 min
(e) 30 min
(h) ROSC, CM 7 min I
(i) ROSR, 13.7 min
(j) 30 min
Figure 1: Sequential changes of ECG (upper) and ABP (lower) of the second rabbit of the control group (left column) and the ﬁfth of
the insulin group (right column), respectively. Lead II surface ECG was recorded at 25mm/sec and 10mm/mV. In the second rabbit of the
control group, (a) during the baseline period, the values were; HR, 152bpm, and QRS, 40ms. (b) Bupivacaine injection caused sinus arrest
and CVC. (c) At ROSC, CM stopped: HR, 205bpm; QRS, 108ms. (d) At ROSR: HR, 210bpm; QRS, 82ms. (e) At 30min after CVC: HR,
212bpm; QRS, 44ms. In the ﬁfth rabbit of the insulin group, (f) At baseline period: HR, 150bpm; QRS, 48ms. (g) Sinus arrest and CVC.
(h) At ROSC, CM stopped: HR, 125bpm; QRS, 200ms. (i) At ROSR: HR, 225bpm; QRS, 68ms. (j) at 30min after CVC: HR, 232bpm;
QRS, 48ms. ECG: electrocardiogram; ABP: arterial blood pressure; bpm: beats per min; ms: millisecond; CVC: cardiovascular collapse; CM:
cardiac massage; ROSC: return of spontaneous circulation; ROSR: return of sinus rhythm.Anesthesiology Research and Practice 5
Table 2: Changes of arterial blood gas, serum electrolyte, and blood glucose concentration in the control and insulin groups.
Group Baseline CVC 5min 10min 15min 20min 25min 30min
pH Control 7.47 ±0.03 7.50 ±0.08 7.40 ±0.06 7.40 ±0.07 7.37 ±0.09 7.36 ±0.10 7.35 ±0.10 7.37 ±0.08
Insulin 7.48 ±0.07 7.51 ±0.05 7.44 ±0.06 7.45 ±0.05 7.41 ±0.05 7.41 ±0.06 7.41 ±0.06 7.42 ±0.06
PaO2 Control 139 ±16 173 ±33 353 ±117† 330 ±147† 379 ±120† 370 ±75† 340 ±87† 333 ±116†
(mmHg) Insulin 137 ±30 198 ±98 351 ±111† 430 ±66† 399 ± 81† 397 ±65† 401 ±79† 426 ±103†
PaCO2 Control 34 ±42 4 ±5† 34 ±33 5 ±33 9 ±84 2 ±84 3 ±94 2 ±7
(mmHg) Insulin 34 ±42 7 ±4† 29 ±52 9 ±53 7 ±73 8 ±63 8 ±63 8 ±6
Na+ Control 143 ±4 143 ±5 145 ±5 145 ±6 146 ±6† 148 ±6† 147 ±5† 148 ±5†
(mEq/L) Insulin 142 ±3 142 ±4 143 ±3 144 ±4 146 ±4† 146 ±3† 146 ±3† 147±4†
K+ Control 2.9 ±0.42 .7 ±0.52 .8 ±0.52 .9 ±0.63 .0 ±0.43 .0 ±0.53 .0 ±0.52 .8 ±0.5
(mEq/L) Insulin 3.0 ±0.32 .8 ±0.42 .8 ±0.62 .8 ±0.6† 2.8 ±0.5† 2.7 ±0.4† 2.8 ±0.4† 2.7 ±0.3†
Ca++ Control 2.52 ±0.21 1.98 ±0.29† 2.08 ±0.38† 2.11 ±0.41† 1.99 ±0.42† 2.03 ±0.42† 2.02 ±0.35† 2.08 ±0.28†
(mEq/L) Insulin 2.79 ±0.32 2.32 ±0.21† 2.28 ±0.29† 2.28 ±0.29† 2.36 ±0.23† 2.45 ±0.24† 2.46 ±0.22† 2.47 ±0.18†
Glucose Control 256 ±47 248 ±50 261 ±48 260 ±63 242 ±44 252 ±71 255 ±76 251 ±74
(mg/dL) Insulin 262 ±56 245 ±70 230 ±84 228 ±90 197±55† 179 ±53† 167 ±54† 152 ±56†
Values are mean ± SD.
CVC: cardiovascular collapse.
∗P<0.05 versus control; †P<0.05 versus baseline.
on lowering plasma potassium levels, potassium was not
added to the insulin-treated group. Hypokalemia can
increase resting membrane potential and action potential
height [19]. Thus, there might be a possibility that insulin-
induced hypokalemia may enhance sodium inward current.
However, hypokalemia may worsen toxicity by lengthening
action potential duration [3], which was not believed to play
a major role in reversing bupivacaine-induced cardiotoxicity
[5]. Glucose was maintained above normal in both groups.
The positive inotropic eﬀects of insulin have been shown to
be independent of the presence of glucose [11]. Despite of
signiﬁcant decrease in calcium level in both groups, serum
calciumwasmaintainedwithinthenormalrangethroughout
the experiment.
The limitation of this study is that experimental animals
were mechanically ventilated to keep normocapnia with
100% oxygen and pH was controlled with sodium bicarbon-
ate from the beginning of CVC. Hypoxia and hyperkalemia,
known to increase bupivacaine’s depressive eﬀects [3, 20],
were prevented. These might reduce the occurrence of severe
arrhythmia such as ventricular tachycardia. Though this
study was not blindly performed, internal cardiac massage
was so eﬀective that all animals survived. Because hemody-
namics and bupivacaine concentration changes were similar
between both groups, insulin eﬀect on the recovery of car-
diac contractility and conduction could be compared while
minimizing the investigator bias. In spite of the fact that
b u p i v a c a i n es e e m st or e n d e rm y o c a r d i u mr e f r a c t o r yt od e ﬁ -
brillation [21], interaction or comparison of other treatment
modalities with insulin therapy needs further investigations.
Inconclusion,asingleinjectionofinsulincombinedwith
opencardiaccompressionwashelpfultorestorespontaneous
circulation and sinus rhythm after abrupt induction of CVC
caused by a bolus injection of bupivacaine in rabbits. The
result suggests that insulin therapy might be considered as
a supplement to enhance cardiac contractility as well as to
facilitate myocardial conduction for bupivacaine-induced
cardiac toxicity.
Implication Statement
Insulin enhances myocardial contractility and recovery of
regular sinus rhythm from bupivacaine-induced cardiovas-
cular collapse. However, the restoration of cardiac conduc-
tion is considered to be mainly dependent on the change of
plasma bupivacaine concentrations.
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